WORKING OUT OF STRATEGY OF STOREKEEPING OF PHARMACEUTICAL FIRM

Research of experience of the firm which is engaged in pharmaceutical business, has confirmed necessity of working out the scientifically-proved strategy of storekeeping by different groups of medicines. Instability of economy during the periods of crisis, instability of prices on pharmaceutical pro...

Full description

Saved in:
Bibliographic Details
Main Author: A. I. Borodin (Author)
Format: Book
Published: IRBIS LLC, 2015-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_d62c085d0b7b4cd69b2f51e824f60b5d
042 |a dc 
100 1 0 |a A. I. Borodin  |e author 
245 0 0 |a WORKING OUT OF STRATEGY OF STOREKEEPING OF PHARMACEUTICAL FIRM 
260 |b IRBIS LLC,   |c 2015-03-01T00:00:00Z. 
500 |a 2070-4909 
500 |a 2070-4933 
520 |a Research of experience of the firm which is engaged in pharmaceutical business, has confirmed necessity of working out the scientifically-proved strategy of storekeeping by different groups of medicines. Instability of economy during the periods of crisis, instability of prices on pharmaceutical production and inflation generate risks, both for firm, and for its foreign partners. For the purpose of optimum strategy creation storekeeping of medicines is grouped by consumer properties, for each group demand is investigated and depending on features of demand optimum strategy of storekeeping with use of dynamic models, periodic and with critical level is developed. Efficiency is received at the expense of economy of operating assets, improvements of servicing and increase of attractiveness of pharmaceutical business for domestic and foreign partners-suppliers of production. 
546 |a RU 
690 |a medical products 
690 |a working capital 
690 |a stock norm 
690 |a management strategy 
690 |a demand modeling 
690 |a seasonal prevalence of sale 
690 |a network of stocks movement 
690 |a critical rate strategic 
690 |a threshold level of stock 
690 |a order volume 
690 |a storage costs 
690 |a organization costs 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Economics as a science 
690 |a HB71-74 
655 7 |a article  |2 local 
786 0 |n Фармакоэкономика, Vol 5, Iss 2, Pp 34-36 (2015) 
787 0 |n https://www.pharmacoeconomics.ru/jour/article/view/32 
787 0 |n https://doaj.org/toc/2070-4909 
787 0 |n https://doaj.org/toc/2070-4933 
856 4 1 |u https://doaj.org/article/d62c085d0b7b4cd69b2f51e824f60b5d  |z Connect to this object online.